Sources of Lab polyclonals

Extra-Large Aperture Assortment 10 each of 800 and 1000 um aperture Dual-Thickness MicroLoops
M5-L18SP-A6 MiTeGen 20 MOUNTS 112 EUR
Medium Aperture Assortment 5 each of 50, 100, 150 and 200 um aperture Dual-Thickness MicroLoops
M5-L18SP-A4 MiTeGen 20 MOUNTS 112 EUR
Sieve SS 200mm 13.2mm Aperture - EACH
SIE1002 Scientific Laboratory Supplies EACH 143.94 EUR
Sieve SS 200mm 11.2mm Aperture - EACH
SIE1004 Scientific Laboratory Supplies EACH 143.94 EUR
Sieve SS 200mm 9.5mm Aperture - EACH
SIE1006 Scientific Laboratory Supplies EACH 143.94 EUR
Sieve SS 200mm 8.0mm Aperture - EACH
SIE1008 Scientific Laboratory Supplies EACH 143.94 EUR
Sieve SS 200mm 6.7mm Aperture - EACH
SIE1010 Scientific Laboratory Supplies EACH 143.94 EUR
Sieve SS 200mm 5.6mm Aperture - EACH
SIE1012 Scientific Laboratory Supplies EACH 143.94 EUR
Sieve SS 200mm 4mm Aperture - EACH
SIE1016 Scientific Laboratory Supplies EACH 132.19 EUR
Sieve SS 200mm 2.8mm Aperture - EACH
SIE1020 Scientific Laboratory Supplies EACH 116.04 EUR
Sieve SS 200mm 2mm Aperture - EACH
SIE1024 Scientific Laboratory Supplies EACH 116.04 EUR
Sieve SS 200mm 1.7mm Aperture - EACH
SIE1026 Scientific Laboratory Supplies EACH 116.04 EUR
Sieve SS 200mm 1.4mm Aperture - EACH
SIE1028 Scientific Laboratory Supplies EACH 116.04 EUR
Sieve SS 200mm 1mm Aperture - EACH
SIE1032 Scientific Laboratory Supplies EACH 116.04 EUR
Sieve SS 200mm 0.6mm Aperture - EACH
SIE1038 Scientific Laboratory Supplies EACH 116.04 EUR
Sieve SS 200mm 0.5mm Aperture - EACH
SIE1040 Scientific Laboratory Supplies EACH 116.04 EUR
Sieve SS 200mm 0.3mm Aperture - EACH
SIE1046 Scientific Laboratory Supplies EACH 116.04 EUR
Sieve SS 200mm 16mm Aperture - EACH
SIE1000 Scientific Laboratory Supplies EACH 143.94 EUR
Sieve SS 200mm 4.75mm Aperture - EACH
SIE1014 Scientific Laboratory Supplies EACH 143.94 EUR
Sieve SS 200mm 3.35mm Aperture - EACH
SIE1018 Scientific Laboratory Supplies EACH 116.04 EUR
Sieve SS 200mm 2.36mm Aperture - EACH
SIE1022 Scientific Laboratory Supplies EACH 116.04 EUR
Sieve SS 200mm 1.18mm Aperture - EACH
SIE1030 Scientific Laboratory Supplies EACH 116.04 EUR
Sieve SS 200mm 0.85mm Aperture - EACH
SIE1034 Scientific Laboratory Supplies EACH 116.04 EUR
Sieve SS 200mm 0.71mm Aperture - EACH
SIE1036 Scientific Laboratory Supplies EACH 116.04 EUR
Sieve SS 200mm 0.425mm Aperture - EACH
SIE1042 Scientific Laboratory Supplies EACH 116.04 EUR
Sieve SS 200mm 0.355mm Aperture - EACH
SIE1044 Scientific Laboratory Supplies EACH 116.04 EUR
Sieve SS 200mm 0.25mm Aperture - EACH
SIE1048 Scientific Laboratory Supplies EACH 116.04 EUR
Sieve SS 200mm 0.212mm Aperture - EACH
SIE1050 Scientific Laboratory Supplies EACH 116.04 EUR
Sieve SS 200mm 0.15mm Aperture - EACH
SIE1054 Scientific Laboratory Supplies EACH 116.04 EUR
Sieve SS 200mm 0.106mm Aperture - EACH
SIE1058 Scientific Laboratory Supplies EACH 116.04 EUR
Sieve SS 200mm 0.09mm Aperture - EACH
SIE1060 Scientific Laboratory Supplies EACH 116.04 EUR
Sieve SS 200mm 0.075mm Aperture - EACH
SIE1062 Scientific Laboratory Supplies EACH 116.04 EUR
Sieve SS 200mm 0.063mm Aperture - EACH
SIE1064 Scientific Laboratory Supplies EACH 116.04 EUR
Sieve SS 200mm 0.045mm Aperture - EACH
SIE1068 Scientific Laboratory Supplies EACH 202.69 EUR
Sieve SS 200mm 0.038mm Aperture - EACH
SIE1070 Scientific Laboratory Supplies EACH 211.51 EUR
Sieve SS 200mm 0.10mm Aperture - EACH
SVMT511 Scientific Laboratory Supplies EACH 116.04 EUR
Sieve SS 200mm 0.20mm Aperture - EACH
SVMT519 Scientific Laboratory Supplies EACH 116.04 EUR
Screwcaps C/W Aperture Red - PK10
2922705 Scientific Laboratory Supplies PK10 25.65 EUR
MicroMount Small Aperture Assortment -5 each of 10, 20, 30 and 50 micron aperture mounts; mounted on 18 mm rods
M2-L18SP-A1 MiTeGen 20 MOUNTS 112 EUR
MicroMount Medium Aperture Assortment - 5 each of 75, 100, 150 and 200 micron aperture mounts; mounted on 18 mm rods
M2-L18SP-A2 MiTeGen 20 MOUNTS 112 EUR
MicroLoops LD; Small aperture assortment; 5 each of 20, 30, 50 and 75 micron aperture loops; mounted on 18 mm rods
M5-L18SP-A1LD MiTeGen 20 MOUNTS 112 EUR
MicroLoops LD; Medium aperture assortment; 5 each of 100, 150, 200 and 300 micron aperture loops; mounted on 18 mm rods
M5-L18SP-A2LD MiTeGen 20 MOUNTS 112 EUR
MicroLasso; 300 µm wide aperture. Box of 20.
T2-L25-12 MiTeGen 1 MicroTool 118 EUR
UV-VIS 100 Micron aperture MicroLoops (20 mounts total, on 18 mm pins)
MUV-L18SP-M5100 MiTeGen 20 MOUNTS 224 EUR
MicroGrippers; box of 20 with 100 micron aperture; mounted on 18 mm rods
M7-L18SP-100 MiTeGen 20 MOUNTS 112 EUR
MicroGrippers; box of 20 with 200 micron aperture; mounted on 18 mm rods
M7-L18SP-200 MiTeGen 20 MOUNTS 112 EUR
MicroGrippers; box of 20 with 300 micron aperture; mounted on 18 mm rods
M7-L18SP-300 MiTeGen 20 MOUNTS 112 EUR
MicroGrippers; box of 20 with 50 micron aperture; mounted on 18 mm rods
M7-L18SP-50 MiTeGen 20 MOUNTS 112 EUR
Lovibond TR 520 (8mm and 4mm Aperture) Reflectance Spectrocolorimeter - EACH
COL1022 Scientific Laboratory Supplies EACH 7981.46 EUR
Crystal Harvesting Sampler Kit 1 contains: 10 Dual-Thickness MicroMounts - 5 each of 50μm & 100μm apertures 5 MicroMeshes - 5 of the 400/25μm aperture 5 Dual-Thickness MicroLoops - 5 of the 200μm aperture 10 Dual-Thickness MicroLoops LD - 5 each of 50μm &
MSK-1 MiTeGen 1 KIT 214 EUR
MicroLoops LD; box of 20 with 100 micron aperture loops; mounted on 18 mm rods
M5-L18SP-100LD MiTeGen 20 MOUNTS 112 EUR
MicroLoops LD; box of 20 with 150 micron aperture loops; mounted on 18 mm rods
M5-L18SP-150LD MiTeGen 20 MOUNTS 112 EUR
MicroLoops LD; box of 20 with 200 micron aperture loops; mounted on 18 mm rods
M5-L18SP-200LD MiTeGen 20 MOUNTS 112 EUR
MicroLoops LD; box of 20 with 20 micron aperture loops; mounted on 18 mm rods
M5-L18SP-20LD MiTeGen 20 MOUNTS 112 EUR
MicroLoops LD; box of 20 with 300 micron aperture loops; mounted on 18 mm rods
M5-L18SP-300LD MiTeGen 20 MOUNTS 112 EUR
MicroLoops LD; box of 20 with 35 micron aperture loops; mounted on 18 mm rods
M5-L18SP-35LD MiTeGen 20 MOUNTS 112 EUR
MicroLoops LD; box of 20 with 50 micron aperture loops; mounted on 18 mm rods
M5-L18SP-50LD MiTeGen 20 MOUNTS 112 EUR
MicroLoops LD; box of 20 with 75 micron aperture loops; mounted on 18 mm rods
M5-L18SP-75LD MiTeGen 20 MOUNTS 112 EUR
Inclined MicroLoops E; box of 20 each 15x150 um aperture mounted on 18 mm rods
M8-L18SP-15I MiTeGen 20 MOUNTS 112 EUR
Vertical MicroLoops E; box of 20 each 15x150 um aperture mounted on 18 mm rods
M8-L18SP-15V MiTeGen 20 MOUNTS 112 EUR
Vertical MicroLoops E; box of 20 each 30x300 um aperture mounted on 18 mm rods
M8-L18SP-30V MiTeGen 20 MOUNTS 112 EUR
Inclined MicroLoops E; box of 20 each 50x500 um aperture mounted on 18 mm rods
M8-L18SP-50I MiTeGen 20 MOUNTS 112 EUR
Vertical MicroLoops E; box of 20 each 50x500 um aperture mounted on 18 mm rods
M8-L18SP-50V MiTeGen 20 MOUNTS 112 EUR
Vertical MicroLoops E; box of 20 each 70x700 um aperture mounted on 18 mm rods
M8-L18SP-70V MiTeGen 20 MOUNTS 112 EUR
Horizontal MicroLoops E; box of 20 each 15x150 um aperture mounted on 18 mm rods
M8-L18SP-15H MiTeGen 20 MOUNTS 112 EUR
Horizontal MicroLoops E; box of 20 each 50x500 um aperture mounted on 18 mm rods
M8-L18SP-50H MiTeGen 20 MOUNTS 112 EUR

Compare antibodies lab reagents for research



Suppliers for Lab ELISAs

HCV-IN-3

MBS3845392-1mg MyBiosource 1mg

HCV-IN-3

MBS3845392-5mg MyBiosource 5mg

HCV-IN-3

MBS3845392-5x10mg MyBiosource 5x10mg

HCV-IN-3

MBS5766792-5mg MyBiosource 5mg

HCV-IN-3

MBS5766792-5x5mg MyBiosource 5x5mg

HCV-IN-7

MBS5766799-5mg MyBiosource 5mg

HCV-IN-7

MBS5766799-5x5mg MyBiosource 5x5mg

Recombinant Humanp21 Recombinant Protein

92-035 ProSci 0.05 mg 821.4 EUR

TWEAK, recombinant / TNFSF12, recombinant (Human)

054-85 PHOENIX PEPTIDE 10 μg 261.36 EUR

TAGLN Recombinant Protein (Rat) (Recombinant- Tag)

RP232205 ABM 100 ug Ask for price

TAGLN2 Recombinant Protein (Rat) (Recombinant Tag)

RP232208 ABM 100 ug Ask for price

TAGLN3 Recombinant Protein (Rat) (Recombinant Tag)

RP232211 ABM 100 ug Ask for price

TAGLN3 Recombinant Protein (Rat) (Recombinant Tag)

RP232214 ABM 100 ug Ask for price

TAGAP Recombinant Protein (Human) (Recombinant- Tag)

RP030880 ABM 100 ug Ask for price

TAGLN Recombinant Protein (Human) (Recombinant- Tag)

RP030883 ABM 100 ug Ask for price

Our used monoclonals in Pubmed.

Anti- GPR162 Antibody Antibody

GWB-AAD3BE GenWay Biotech 0.05 ml Ask for price

Anti- GPR162 Antibody Antibody

GWB-C5010A GenWay Biotech 0.05 ml Ask for price

Anti-CD31 Antibody Antibody

MBS8304163-003mL MyBiosource 0.03mL 185 EUR

Anti-CD31 Antibody Antibody

MBS8304163-01mL MyBiosource 0.1mL 255 EUR

Anti-CD31 Antibody Antibody

MBS8304163-02mL MyBiosource 0.2mL 335 EUR

Compare Pcr lab reagents for research




Suppliers for Lab rec.

Lenti-EF1α-Sox2 Virus

G427 ABM 100 μl, Titer: 10^6 IU/ml
Description: N/A

Lenti-SFFV-KLF4 Virus

G432 ABM 100 μl, Titer: 10^6 IU/ml
Description: N/A

Lenti-SFFV-Oct4 Virus

G439 ABM 100 μl, Titer: 10^6 IU/ml
Description: N/A

Lenti-SFFV-Sox2 Virus

G440 ABM 100 μl, Titer: 10^6 IU/ml
Description: N/A

Lenti-III-EF1α Vector

LV043 ABM 10 μg

lenti MS2-P65-HSF1_Hygro

PVTY00190 Nova Lifetech 2ug

Lenti-EF1α-Nanog Virus

G424 ABM 100 μl, Titer: 10^6 IU/ml
Description: N/A

Monoclonal GR monoclonal antibody

AMM00029G Leading Biology 0.05mg 633.6 EUR

Monoclonal TBP monoclonal antibody

APR13720G Leading Biology 0.1ml 633.6 EUR

Monoclonal EZH2 monoclonal antibody

AMM00030G Leading Biology 0.05mg 633.6 EUR

Monoclonal Rsf1 monoclonal antibody

AMM07673G Leading Biology 0.05mg 633.6 EUR

Monoclonal Rsf1 monoclonal antibody

AMM07674G Leading Biology 0.1ml 633.6 EUR

Monoclonal HDAC2 monoclonal antibody

AMM00031G Leading Biology 0.05mg 633.6 EUR

Monoclonal SirT1 monoclonal antibody

APR09951G Leading Biology 0.05mg 580.8 EUR

Monoclonal SirT1 monoclonal antibody

APR09952G Leading Biology 0.1ml 580.8 EUR

Our used monoclonals in Pubmed.

Rec FLA-ST

tlrl-flic-10 InvivoGen FR 10 µg 295.05 EUR

Rec FLA-ST

tlrl-flic-50 InvivoGen FR 50 µg 731.85 EUR

rec EGF (human)

4030572.01 Bachem 0.1 mg 102.27 EUR

rec EGF (human)

4030572.05 Bachem 0.5 mg 271.85 EUR

rec EGF (human)

H-7490.0100 Bachem 0.1mg 194.4 EUR

The Regulation of Nitrate Reductases in Response to Abiotic Stress in Arabidopsis TRANSLATE Journal: International Journ

The two homologous genes, NIA1 and NIA2, encode nitrate reductases in Arabidopsis, which govern the reduction of nitrate to nitrite. This step is the rate-limiting step of the nitrate assimilation and utilization. Therefore, the regulation of NIA1 and NIA2 is important for plant development and growth. Although they are similar in sequence and structure, their regulations are different. Genetic analysis uncovers that NIA1, rather than NIA2, plays a predominant role in adopting to ABA stress. Although both long-term stress conditions can cause an improvement in NIA1 levels, a decrease in NIA1 levels under short-term treatments seems to be necessary for plants to switch from the growth status into the adopting status. Interestingly, the downregulation of the NR is distinct under different stress conditions. Under ABA treatment, the NR proteins are degraded via a 26S-proteasome dependent manner, while the transcriptional regulation is the main manner to rapidly reduce the NIA1 levels under nitrogen deficiency and NaCl stress conditions. These results indicate that under stress conditions, the regulation of NIA1 is complex, and it plays a key role in regulating the balance between growth and adaptation.

Evaluation of the Simpson’s Method to Determine Left Ventricular Ejection Fraction Using the Transgastric Two-Chamber View

Introduction: Left ventricular chamber size and functional assessment by transesophageal echocardiography can be difficult if visualization is poor in the mid-esophageal views. However, the accuracy of using the Simpson’s method in the transgastric 2-chamber (TG2C) as an alternative approach has not been assessed.
Methods: The Simpson’s method was performed by 2 independent reviewers using midesophageal 2-chamber (ME2C) and TG2C views. Echocardiographic images were retrieved retrospectively for 49 adult cardiac surgical patients.
Results: Two-way random effects intraclass correlation coefficients demonstrated no significant interobserver variability. Linear mixed effects models showed no significant differences in ME2C and TG2C measurements with regard to EDV (P=.4407), ESV (P=.5113), or EF (P=.0610).Compared to the ME2C view, the TG2C view had better image quality of the LV walls (image quality score median [interquartile range]: 2.00 [.00] vs 1.00 [1.00]; P<.0001), but worse image quality of the mitral annulus (1.00 [1.00] vs 2.00 [.00]; P<.0001) and LV apex (.00 [1.00] vs 2.00 [1.00]; P<.0001).
Conclusions: This study suggests the Simpson’s method can be applied to the TG2C view as an alternative to the standard midesophageal method to estimate chamber volumes and EF.
Keywords: Simpson’s method; intraoperative assessment; left ventricular ejection fraction; monitoring; research; transesophageal echocardiography.

Intracellular MUC20 variant 2 maintains mitochondrial calcium homeostasis and enhances drug resistance in gastric cancer

Background: Signet ring cell carcinoma (SRCC) is a particular histologic variant of gastric cancer (GC). However, the critical factor related to the aggressive characteristics of SRCC has not been determined.
Methods: We collected surgically resected tissues from 360 GC patients in the Kumamoto University cohort and generated survival curves via the Kaplan-Meier method. In vitro, we identified the specific transcript variant of MUC20 in SRCC cells by direct sequencing and investigated the role of MUC20 in GC progression using GC cells with MUC20 silencing and forced expression. In vivo, we examined chemoresistance using MUC20 variant 2 (MUC20v2)-overexpressing non-SRCC cells to construct a xenograft mouse model.
Results: We analyzed a comprehensive GC cell line database to identify the specifically expressed genes in gastric SRCC. We focused on MUC20 and investigated its role in GC progression. Survival analysis revealed that GC patients with high MUC20 expression exhibited a poor prognosis and that MUC20 expression was significantly correlated with SRCC histological type. Moreover, we found that gastric SRCC cells specifically expressed MUC20v2, which was dominantly expressed in the cytoplasm. Silencing MUC20v2 caused cell death with characteristic morphological changes in gastric SRCC cells. To further determine the types of cell death, we examined apoptosis, pyroptosis and ferroptosis by detecting cleaved PARP, gasdermin E-N-terminal (GSDME-N), and lipid reactive oxygen species (ROS) levels, respectively. We found that apoptosis and pyroptosis occurred in MUC20-silenced gastric SRCC cells. In addition, MUC20v2-overexpressing GC cells exhibited chemoresistance to cisplatin (CDDP) and paclitaxel (PTX). RNA sequencing revealed that the pathways involved in intracellular calcium regulation were significantly upregulated in MUC20v2-overexpressing GC cells.
Notably, forced expression of MUC20v2 in the cytoplasm of GC cells led to the maintenance of mitochondrial calcium homeostasis and mitochondrial membrane potential (MMP), which promoted cell survival and chemoresistance by suppressing apoptosis and pyroptosis. Finally, we investigated the significance of MUC20v2 in a xenograft model treated with CDDP and showed that MUC20v2 overexpression caused chemoresistance by inhibiting cell death.
Conclusion: These findings highlight the novel functions of MUC20v2, which may confer cell survival and drug resistance in GC cells.
Significance: MUC20v2 protects GC cells from apoptosis and pyroptosis by maintaining mitochondrial calcium levels and mitochondrial membrane potential and subsequently induces drug resistance.
Keywords: Drug resistance; Intracellular mucin 20; Mitochondrial calcium homeostasis; Mitochondrial membrane potential; Signet ring cell carcinoma.

Antioxidant, Antimicrobial Activities and Characterization of Polyphenol-Enriched Extract of Egyptian Celery ( Apium graveolens L., Apiaceae) Aerial Parts via UPLC/ESI/TOF-MS

Medicinal plant extracts are increasingly considered a major source of innovative medications and healthcare products.
This study focused on preparing a polyphenol enriched water extract of Egyptian celery “Apium graveolens L., Apiaceae” aerial parts (TAE) in an endeavor to accentuate its antioxidant capacity as well as its antimicrobial activity. (TAE) of celery was partitioned against different organic solvents to yield dichloromethane (DCM), ethyl acetate (EAC), and butanol (BUOH) fractions. (TAE) and the organic fractions thereof besides the remaining mother liquor (ML) were all screened for their antioxidant capacity using various protocols viz. monitoring the reducing amplitudes for ferric ions (FRAP), and radical scavenging potentials of oxygen (ORAC), 2,2′-azino-bis-3-ethylbenzothiazoline-6-sulfonic acid (ABTS), 2,2-diphenyl-1-picrylhydrazyl (DPPH), and metal chelation assays.
The examination procedure revealed both (TAE) extract and (DCM) fraction, to pertain the highest antioxidant potentials, where the IC50 of the (TAE) using ABTS and metal chelation assays were ca. 34.52 ± 3.25 and 246.6 ± 5.78 µg/mL, respectively. The (DCM) fraction recorded effective results using the FRAP, ORAC, and DPPH assays ca. 233.47 ± 15.14 and 1076 ± 25.73 μM Trolox equivalents/mg sample and an IC50 474.4 ± 19.8 µg/mL, respectively.
Additionally, both (TAE) and (DCM) fraction exerted antimicrobial activities recording inhibition zones (mm) (13.4 ± 1.5) and (12.0 ± 1.0) against Staphylococcus aureus and (11.0 ± 1.2) and (10.0 ± 1.3) against Escherichia coli, respectively, with no anti-fungal activity. Minimum inhibitory concentration (MIC) of (TAE) and (DCM) fraction were 1250 and 2500 µg/mL, respectively. UPLC/ESI/TOF-MS unveiled the chemical profile of both (TAE) and (DCM) fraction to encompass a myriad of active polyphenolic constituents including phenylpropanoids, coumarins, apigenin, luteolin, and chrysoeriol conjugates.

Real world data on cardiometabolic diseases in U.S. adults during the SARS-CoV-2 pandemic: a decentralized registry study

Background: Pre-existing cardiometabolic comorbidities place SARS-CoV-2 positive patients at a greater risk for poorer clinical course and mortality than those without it. We aimed to analyze real-world registry data focused primarily on participants with cardiometabolic diseases (CMD), which were remotely obtained via a digital platform.
Methods: Participants were divided into two groups: CMD or no cardiometabolic disease (non-CMD). They were evaluated based on their medical history, current medications/supplements, COVID-19 status, demographics, and baseline characteristics. The frequency of medications/supplements for CMD were compared using relative risks and 95% confidence intervals. The WHO (Five) Well-Being Index (WHO-5) were collected monthly for 6 months to assess psychological well-being which included cheerfulness, calmness, vigor, rest, and engagement with daily activities of interest.
Results: The 791 enrollees represented 49 U.S. states.
The CMD group had significantly higher (p < 0.0001) BMI (mean + 3.04 kg/m2) and age (mean + 9.15 years) compared to non-CMD group. In the CMD group, participants who tested positive for COVID-19 had lower (p < 0.0001) well-being scores than those without COVID-19. For the 274 participants on CMD medications/supplements, there was no statistical difference in risk of COVID-19 contracture based on medication/supplement type; however, all six participants who were not being treated for CMD were COVID-19 positive (RR ~ 104). For 89 participants who were on treatment for diabetes or insulin resistance, there was a 90% reduced risk of COVID-19 incidence (p = 0.0187).

DMEM/F12

from Elabscience Biotech
PM150312-500mL | 500 mL: 10.00 EUR

DMEM/F12

from Elabscience Biotech
PM150312 | 500mL: 10.00 EUR

DMEM/F12

from MyBiosource
MBS2567519-500mL | 500mL: 80.00 EUR

DMEM/F12

from MyBiosource
MBS2567519-5x500mL | 5x500mL: 360.00 EUR

Special DMEM

from Addexbio
C0003-06 | RT 500 mL Bottle: 66.70 EUR

Optimized DMEM

from Addexbio
C0003-02 | RT 500 mL Bottle: 23.99 EUR

Formulated DMEM

from Addexbio
C0003-01 | RT 500 mL Bottle: 22.99 EUR

Specialized DMEM

from Addexbio
C0003-03 | RT 500 mL Bottle: 30.00 EUR

DMEM/F-12

from Addexbio
C0013-16 | RT 500 mL Bottle: 28.99 EUR

SILAC - DMEM/F12

from AthenaES
0423 | 500 ml: 41.50 EUR

SILAC- DMEM/F12

from AthenaES
0433 | 1L: 33.70 EUR
Conclusion: The well-being score of the CMD group was dependent on whether they tested positive for COVID-19. Type of CMD treatment did not impact COVID-19 status, but absence of treatment significantly increased COVID-19 incidence. With respect to SARS-CoV-2, our analysis supports continued use of the statins, ACE-I, ARBs, and diabetes medications in CMD patients.
Trial registration: ClinicalTrials.gov Identifier: NCT04348942.
Keywords: Angiotensin; Cardiovascular; Diabetes; Insulin resistance; Metabolism; SARS-CoV-2.

Genome-Wide Characterization of SARS-CoV-2 Cytopathogenic Proteins in the Search of Antiviral Targets

Therapeutic inhibition of critical viral functions is important for curtailing coronavirus disease 2019 (COVID-19). We sought to identify antiviral targets through the genome-wide characterization of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) proteins that are crucial for viral pathogenesis and that cause harmful cytopathogenic effects.
All 29 viral proteins were tested in a fission yeast cell-based system using inducible gene expression. Twelve proteins, including eight nonstructural proteins (NSP1, NSP3, NSP4, NSP5, NSP6, NSP13, NSP14, and NSP15) and four accessory proteins (ORF3a, ORF6, ORF7a, and ORF7b), were identified that altered cellular proliferation and integrity and induced cell death. Cell death correlated with the activation of cellular oxidative stress. Of the 12 proteins, ORF3a was chosen for further study in mammalian cells because it plays an important role in viral pathogenesis and its activities are linked to lung tissue damage and a cytokine storm.
In human pulmonary and kidney epithelial cells, ORF3a induced cellular oxidative stress associated with apoptosis and necrosis and caused activation of proinflammatory response with production of the cytokines tumor necrosis factor alpha (TNF-α), interleukin-6 (IL-6), and IFN-β1, possibly through the activation of nuclear factor kappa B (NF-κB).
To further characterize the mechanism, we tested a natural ORF3a Beta variant, Q57H, and a mutant with deletion of the highly conserved residue, ΔG188. Compared with wild-type ORF3a, the ΔG188 variant yielded more robust activation of cellular oxidative stress, cell death, and innate immune response. Since cellular oxidative stress and inflammation contribute to cell death and tissue damage linked to the severity of COVID-19, our findings suggest that ORF3a is a promising, novel therapeutic target against COVID-19.
 IMPORTANCE The ongoing COVID-19 pandemic caused by SARS-CoV-2 has claimed over 5.5 million lives with more than 300 million people infected worldwide. While vaccines are effective, the emergence of new viral variants could jeopardize vaccine protection. Treatment of COVID-19 by antiviral drugs provides an alternative to battle against the disease. The goal of this study was to identify viral therapeutic targets that can be used in antiviral drug discovery. Utilizing a genome-wide functional analysis in a fission yeast cell-based system, we identified 12 viral candidates, including ORF3a, which cause cellular oxidative stress, inflammation, apoptosis, and necrosis that contribute to cytopathogenicity and COVID-19. Our findings indicate that antiviral agents targeting ORF3a could have a great impact on COVID-19.

Copolymers Containing 1-Methyl-2-phenyl-imidazole Moieties as Permanent Dipole Generating Units: Synthesis, Spectroscopic, Electrochemical, and Photovoltaic Properties

New donor-acceptor conjugated alternating or random copolymers containing 1-methyl-2-phenylbenzimidazole and benzothiadiazole (P1), diketopyrrolopyrrole (P4), or both acceptors (P2) are reported. The specific feature of these copolymers is the presence of a permanent dipole-bearing moiety (1-methyl-2-phenyl imidazole (MPI)) fused with the 1,4-phenylene ring of the polymer main chain.
For comparative reasons, polymers of the same main chain but deprived of the MPI group were prepared, namely, P5 with diketopyrrolopyrrole and P3 with both acceptors. The presence of the permanent dipole results in an increase of the optical band gap from 1.51 eV in P3 to 1.57 eV in P2 and from 1.49 eV in P5 to 1.55 eV in P4. It also has a measurable effect on the ionization potential (IP) and electrochemical band gap (EgCV), leading to their decrease from 5.00 and 1.83 eV in P3 to 4.92 and 1.79 eV in P2 as well as from 5.09 and 1.87 eV in P5 to 4.94 and 1.81 eV in P4.
 Moreover, the presence of permanent dipole lowers the exciton binding energy (Eb) from 0.32 eV in P3 to 0.22 eV in P2 and from 0.38 eV in P5 to 0.26 eV in P4. These dipole-induced changes in the polymer properties should be beneficial for photovoltaic applications. Bulk heterojunction solar cells fabricated from these polymers (with PC71BM acceptor) show low series resistance (rs), indicating good electrical transport properties. The measured power conversion efficiency (PCE) of 0.54% is limited by the unfavorable morphology of the active layer.

Preparation of Naringenin Nanosuspension and Its Antitussive and Expectorant Effects

Naringenin (NRG) is a natural flavonoid compound abundantly present in citrus fruits and has the potential to treat respiratory disorders. However, the clinical therapeutic effect of NRG is limited by its low bioavailability due to poor solubility.
To enhance the solubility, naringenin nanosuspensions (NRG-NSps) were prepared by applying tocopherol polyethylene glycol succinate (TPGS) as the nanocarrier via the media-milling method. The particle size, morphology, and drug-loading content of NRG-NSps were examined, and the stability was evaluated by detecting particle size changes in different physiological media. NRG-NSps exhibited a flaky appearance with a mean diameter of 216.9 nm, and the drug-loading content was 66.7%. NRG-NSps exhibited good storage stability and media stability.
NRG-NSps presented a sustainable release profile, and the cumulative drug-release rate approached approximately 95% within 7 d. NRG-NSps improved the antitussive effect significantly compared with the original NRG, the cough frequency was decreased from 22 to 15 times, and the cough incubation period was prolonged from 85.3 to 121.6 s. Besides, NRG-NSps also enhanced expectorant effects significantly, and phenol red secretion was increased from 1.02 to 1.45 μg/mL. These results indicate that NRG-NSps could enhance the bioavailability of NRG significantly and possess a potential clinical application.
Keywords: antitussive effect; bioavailability; expectorant effect; media-milling method; naringenin nanosuspension.

Distinct effects of volatile and intravenous anaesthetics on presynaptic calcium dynamics in mouse hippocampal GABAergic neurones

Background: General anaesthetics have marked effects on synaptic transmission, but their neuronal and circuit-level effects remain unclear. The volatile anaesthetic isoflurane differentially inhibits synaptic vesicle exocytosis in specific neuronal subtypes, but whether other common anaesthetics also have neurone-subtype-specific actions is unknown.
Methods: We used the genetically encoded fluorescent Ca2+ sensor GCaMP6f to compare the pharmacological effects of isoflurane, sevoflurane, propofol, and ketamine on presynaptic excitability in hippocampal glutamatergic neurones and in hippocampal parvalbumin-, somatostatin-, and vasoactive intestinal peptide-expressing (PV+, SST+, and VIP+, respectively) GABAergic interneurones.
Results: Isoflurane and sevoflurane depressed activity-driven presynaptic Ca2+ transients in a neurone-type-specific manner, with greater potency for inhibition of glutamate and SST+ compared with PV+ and VIP+ neurone presynaptic activation. In contrast, clinical concentrations of propofol (1 μM) or ketamine (15 μM) had no significant effects on presynaptic activation. Propofol potentiated evoked Ca2+ entry in PV+ interneurones but only at a supraclinical concentration (3 μM).

DMEM/F12

from Elabscience Biotech
PM150312-500mL | 500 mL: 10.00 EUR

DMEM/F12

from Elabscience Biotech
PM150312 | 500mL: 10.00 EUR

DMEM/F12

from MyBiosource
MBS2567519-500mL | 500mL: 80.00 EUR

DMEM/F12

from MyBiosource
MBS2567519-5x500mL | 5x500mL: 360.00 EUR

Special DMEM

from Addexbio
C0003-06 | RT 500 mL Bottle: 66.70 EUR

Optimized DMEM

from Addexbio
C0003-02 | RT 500 mL Bottle: 23.99 EUR

Formulated DMEM

from Addexbio
C0003-01 | RT 500 mL Bottle: 22.99 EUR

Specialized DMEM

from Addexbio
C0003-03 | RT 500 mL Bottle: 30.00 EUR

DMEM/F-12

from Addexbio
C0013-16 | RT 500 mL Bottle: 28.99 EUR

SILAC - DMEM/F12

from AthenaES
0423 | 500 ml: 41.50 EUR

SILAC- DMEM/F12

from AthenaES
0433 | 1L: 33.70 EUR

DMEM/F12, HEPES

from Tribioscience
TBS8083-500ML | 500mL: 36.00 EUR

DMEM/F12, powder

from Elabscience Biotech
PM150312P-110L | 1×10 L: 45.00 EUR

DMEM/F12, powder

from Elabscience Biotech
PM150312P-150L | 1×50 L: 158.00 EUR

DMEM/F12, powder

from Elabscience Biotech
PM150312P-51L | 5×1 L: 35.00 EUR

DMEM/F12 (Powder)

from Abbexa
abx295010-100g | 100 µg: Ask for price

DMEM/F12 (Powder)

from Abbexa
abx295010-20g | 20 µg: 62.50 EUR

DMEM/F12 (Powder)

from Abbexa
abx295010-50g | 50 µg: 162.50 EUR
Conclusions: Anaesthetic-agent-selective effects on presynaptic Ca2+ entry have functional implications for hippocampal circuit function during i.v. or volatile anaesthetic-mediated anaesthesia. Hippocampal interneurones have distinct subtype-specific sensitivities to volatile anaesthetic actions on presynaptic Ca2+, which are similar between isoflurane and sevoflurane.
Keywords: calcium; interneurone; isoflurane; ketamine; mechanisms of anaesthesia; presynaptic; propofol; sevoflurane.

Circadian Control of REDOX Reactions in the Macrophage Inflammatory Response

Significance: Macrophages are immune sentinels located throughout the body that function in both the amplification and resolution of the inflammatory response. The circadian clock has emerged as a central regulator of macrophage inflammation. Reduction-oxidation (REDOX) reactions are central to both circadian clock and macrophage function. Recent Advances: Circadian regulation of metabolism controls the macrophage inflammatory response, whereby disruption of the clock causes dysfunctional inflammation. Altering metabolism and reactive oxygen/nitrogen species (RONS) production rescues the inflammatory phenotype of clock-disrupted macrophages.
Critical issues: The circadian clock possesses many layers of regulation. Understanding how REDOX reactions coordinate clock function is critical to uncover the full extent of circadian regulation of macrophage inflammation. We provide insights into how circadian regulation of REDOX affects macrophage pattern recognition receptor signaling, immunometabolism, phagocytosis, and inflammasome activation.
Future directions: Many diseases associated with aberrant macrophage derived inflammation exhibit time of day rhythms in disease symptoms and severity and are sensitive to circadian disruption. Macrophage function is highly dependent on REDOX reactions that signal through RONS. Future studies are needed to evaluate the extent of circadian control of macrophage inflammation, specifically in the context of REDOX signaling.

Sarcopenia Is Associated with Metabolic Syndrome in Korean Adults Aged over 50 Years: A Cross-Sectional Study

This study assessed the association between sarcopenia and metabolic syndrome in Korean adults aged over 50 years. The study obtained data from the Korea National Health and Nutrition Examination Survey (KNHANES, 2008-2011), a cross-sectional and nationally representative survey conducted by the Korean Centers for Disease Control and Prevention. Among the 8363 participants included in this study, the prevalence rate of sarcopenia according to metabolic syndrome was stratified by sex.
Crude odds ratios not adjusted for any variables were 1.827 (1.496-2.231) in males, 2.189 (1.818-2.635) in females, and 2.209 (1.766-2.331) in total participants compared with non-sarcopenia. Model 3, which was adjusted for all variables that could affect sarcopenia and metabolic syndrome, showed significant increases in the odds ratios, to 1.957 (1.587-2.413) in males, 1.779 (1.478-2.141) in females, and 1.822 (1.586-2.095) for total participants. The results suggest that the association between sarcopenia and metabolic syndrome is significant in Korean adults.

Genome-Wide Characterization of SARS-CoV-2 Cytopathogenic Proteins in the Search of Antiviral Targets

Therapeutic inhibition of critical viral functions is important for curtailing coronavirus disease 2019 (COVID-19). We sought to identify antiviral targets through the genome-wide characterization of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) proteins that are crucial for viral pathogenesis and that cause harmful cytopathogenic effects.
All 29 viral proteins were tested in a fission yeast cell-based system using inducible gene expression. Twelve proteins, including eight nonstructural proteins (NSP1, NSP3, NSP4, NSP5, NSP6, NSP13, NSP14, and NSP15) and four accessory proteins (ORF3a, ORF6, ORF7a, and ORF7b), were identified that altered cellular proliferation and integrity and induced cell death. Cell death correlated with the activation of cellular oxidative stress. Of the 12 proteins, ORF3a was chosen for further study in mammalian cells because it plays an important role in viral pathogenesis and its activities are linked to lung tissue damage and a cytokine storm. In human pulmonary and kidney epithelial cells, ORF3a induced cellular oxidative stress associated with apoptosis and necrosis and caused activation of proinflammatory response with production of the cytokines tumor necrosis factor alpha (TNF-α), interleukin-6 (IL-6), and IFN-β1, possibly through the activation of nuclear factor kappa B (NF-κB).
To further characterize the mechanism, we tested a natural ORF3a Beta variant, Q57H, and a mutant with deletion of the highly conserved residue, ΔG188.
Compared with wild-type ORF3a, the ΔG188 variant yielded more robust activation of cellular oxidative stress, cell death, and innate immune response. Since cellular oxidative stress and inflammation contribute to cell death and tissue damage linked to the severity of COVID-19, our findings suggest that ORF3a is a promising, novel therapeutic target against COVID-19.
IMPORTANCE The ongoing COVID-19 pandemic caused by SARS-CoV-2 has claimed over 5.5 million lives with more than 300 million people infected worldwide. While vaccines are effective, the emergence of new viral variants could jeopardize vaccine protection. Treatment of COVID-19 by antiviral drugs provides an alternative to battle against the disease. The goal of this study was to identify viral therapeutic targets that can be used in antiviral drug discovery.
Utilizing a genome-wide functional analysis in a fission yeast cell-based system, we identified 12 viral candidates, including ORF3a, which cause cellular oxidative stress, inflammation, apoptosis, and necrosis that contribute to cytopathogenicity and COVID-19. Our findings indicate that antiviral agents targeting ORF3a could have a great impact on COVID-19.

Copolymers Containing 1-Methyl-2-phenyl-imidazole Moieties as Permanent Dipole Generating Units: Synthesis, Spectroscopic, Electrochemical, and Photovoltaic Properties

New donor-acceptor conjugated alternating or random copolymers containing 1-methyl-2-phenylbenzimidazole and benzothiadiazole (P1), diketopyrrolopyrrole (P4), or both acceptors (P2) are reported. The specific feature of these copolymers is the presence of a permanent dipole-bearing moiety (1-methyl-2-phenyl imidazole (MPI)) fused with the 1,4-phenylene ring of the polymer main chain.
For comparative reasons, polymers of the same main chain but deprived of the MPI group were prepared, namely, P5 with diketopyrrolopyrrole and P3 with both acceptors. The presence of the permanent dipole results in an increase of the optical band gap from 1.51 eV in P3 to 1.57 eV in P2 and from 1.49 eV in P5 to 1.55 eV in P4. It also has a measurable effect on the ionization potential (IP) and electrochemical band gap (EgCV), leading to their decrease from 5.00 and 1.83 eV in P3 to 4.92 and 1.79 eV in P2 as well as from 5.09 and 1.87 eV in P5 to 4.94 and 1.81 eV in P4. 
Moreover, the presence of permanent dipole lowers the exciton binding energy (Eb) from 0.32 eV in P3 to 0.22 eV in P2 and from 0.38 eV in P5 to 0.26 eV in P4. These dipole-induced changes in the polymer properties should be beneficial for photovoltaic applications. Bulk heterojunction solar cells fabricated from these polymers (with PC71BM acceptor) show low series resistance (rs), indicating good electrical transport properties. The measured power conversion efficiency (PCE) of 0.54% is limited by the unfavorable morphology of the active layer.

Preparation of Naringenin Nanosuspension and Its Antitussive and Expectorant Effects

Naringenin (NRG) is a natural flavonoid compound abundantly present in citrus fruits and has the potential to treat respiratory disorders. However, the clinical therapeutic effect of NRG is limited by its low bioavailability due to poor solubility.
To enhance the solubility, naringenin nanosuspensions (NRG-NSps) were prepared by applying tocopherol polyethylene glycol succinate (TPGS) as the nanocarrier via the media-milling method.

DMEM/F12

from Elabscience Biotech
PM150312-500mL | 500 mL: 10.00 EUR

DMEM/F12

from Elabscience Biotech
PM150312 | 500mL: 10.00 EUR

DMEM/F12

from MyBiosource
MBS2567519-500mL | 500mL: 80.00 EUR

DMEM/F12

from MyBiosource
MBS2567519-5x500mL | 5x500mL: 360.00 EUR

Special DMEM

from Addexbio
C0003-06 | RT 500 mL Bottle: 66.70 EUR

Optimized DMEM

from Addexbio
C0003-02 | RT 500 mL Bottle: 23.99 EUR

Formulated DMEM

from Addexbio
C0003-01 | RT 500 mL Bottle: 22.99 EUR

Specialized DMEM

from Addexbio
C0003-03 | RT 500 mL Bottle: 30.00 EUR

DMEM/F-12

from Addexbio
C0013-16 | RT 500 mL Bottle: 28.99 EUR

SILAC - DMEM/F12

from AthenaES
0423 | 500 ml: 41.50 EUR

SILAC- DMEM/F12

from AthenaES
0433 | 1L: 33.70 EUR

DMEM/F12, HEPES

from Tribioscience
TBS8083-500ML | 500mL: 36.00 EUR

DMEM/F12, powder

from Elabscience Biotech
PM150312P-110L | 1×10 L: 45.00 EUR

DMEM/F12, powder

from Elabscience Biotech
PM150312P-150L | 1×50 L: 158.00 EUR

DMEM/F12, powder

from Elabscience Biotech
PM150312P-51L | 5×1 L: 35.00 EUR
The particle size, morphology, and drug-loading content of NRG-NSps were examined, and the stability was evaluated by detecting particle size changes in different physiological media. NRG-NSps exhibited a flaky appearance with a mean diameter of 216.9 nm, and the drug-loading content was 66.7%. NRG-NSps exhibited good storage stability and media stability. NRG-NSps presented a sustainable release profile, and the cumulative drug-release rate approached approximately 95% within 7 d. NRG-NSps improved the antitussive effect significantly compared with the original NRG, the cough frequency was decreased from 22 to 15 times, and the cough incubation period was prolonged from 85.3 to 121.6 s.
Besides, NRG-NSps also enhanced expectorant effects significantly, and phenol red secretion was increased from 1.02 to 1.45 μg/mL. These results indicate that NRG-NSps could enhance the bioavailability of NRG significantly and possess a potential clinical application.

Impact of DPP-4 inhibitors on plasma levels of BNP and NT-pro-BNP in type 2 diabetes mellitus

Background: Dipeptidyl peptidase-4 inhibitors (DPP-4i) decrease glucose levels by regulating incretin peptides in type 2 diabetes mellitus (T2DM). This study aimed to determine the modulatory effect of DPP-4i on brain natriuretic peptide (BNP) and N-terminal pro-brain natriuretic peptide (NT-pro-BNP) in patients with T2DM.
Methods: PubMed, Embase and the Cochrane Library were systematically searched to identify randomized controlled trials (RCTs) evaluating the impact of DPP-4i on BNP or NT-pro-BNP. A fixed- or random-effects model was used for quantitative analysis, according to the heterogeneity. Sensitivity analysis and publication bias were performed using standard methods.
Results: Nine trials with 3056 patients with T2DM were included. Meta-analysis revealed that DPP-4i did not significantly modulate the BNP (0.21 pg/mL, 95% CI – 2.36-2.79) or NT-pro-BNP level (- 7.34 pg/mL, 95% CI – 24.27-9.59). DPP-4i demonstrated no stronger effect on modulating BNP (5.17 pg/mL, 95% CI – 7.48-17.82) or NT-pro-BNP (- 9.95 pg/mL, 95% CI – 44.61-24.71) than active comparators. Pooled analysis was robust and stable after sensitivity analysis.
Conclusions: DPP-4i exhibits no significant effect on modulating BNP or NT-pro-BNP and shows no stronger effect than traditional antidiabetic agents in T2DM.
Keywords: BNP; Dipeptidyl peptidase-4 inhibitors; NT-pro-BNP; Randomized controlled trials; Type 2 diabetes mellitus.

Sociodemographic Determinants of Poles’ Attitudes towards the Forest during the COVID-19 Pandemic

Attitudes towards forest ecosystems have been changing together with human needs, which is amplified with society’s increasing need to spend recreation time in the forest. The phenomenon has been particularly visible during the COVID-19 pandemic. The aim of this study was to determine the attitude of Poles to forests during the COVID-19 pandemic. The research was based on (1) a sociodemographic background questionnaire that consisted of questions about the independent variables and (2) the LAS scale-an independently prepared tool for measuring attitudes towards the forest. In the survey, 1025 people participated (673 women). The age of the subjects was between 19 and 68.
The attitude towards the forest was analysed in three dimensions: Benefits, Involvement, and Fears. The Mann-Whitney U test and Kruskal-Wallis one-way analysis of variance by ranks were used for statistical analysis. Women and people with primary education expressed the most fears connected with going to the forest. Men and people living in the countryside and in small towns, as well as respondents who were professionally active and performing work connected with forests were the most involved in exploring the forest and working for its benefit. Concerning the forest, concerned women, people from the highest age group, respondents with university education, and white-collar workers notice the most benefits from recreational activities in the forest.

Relationship between Translational and Rotational Dynamics of Alkyltriethylammonium-Based Ionic Liquids

1H spin-lattice relaxation experiments have been performed for a series of ionic liquids including bis(trifluoromethanesulfonyl)imide anion and cations of a varying alkyl chain length: triethylhexylammonium, triethyloctylammonium, decyltriethylammonium, dodecyltriethylammonium, triethyltetradecylammonium, and hexadecyltriethylammonium. The relaxation studies were carried out in abroad frequency range covering three orders of magnitude, from 10 kHz to 10 MHz, versus temperature.
On the basis of a thorough, quantitative analysis of this reach data set, parameters characterizing the relative, cation-cation, translation diffusion (relative diffusion coefficients and translational correlation times), and rotational motion of the cation (rotational correlation times) were determined. Relationships between these quantities and their dependence on the alkyl chain length were discussed in comparison to analogous properties of molecular liquids. It was shown, among other findings, that the ratio between the translational and rotational correlation times is smaller than for molecular liquids and considerably dependent on temperature. Moreover, a comparison of relative and self-diffusion coefficients indicate correlated translational dynamics of the cations.

Incorporation of a FRET Pair into a Riboswitch RNA to Measure Mg 2+ Concentration and RNA Conformational Change in Cell

Riboswitches are natural biosensors that can regulate gene expression by sensing small molecules. Knowledge of the structural dynamics of riboswitches is crucial to elucidate their regulatory mechanism and develop RNA biosensors. In this work, we incorporated the fluorophore, Cy3, and its quencher, TQ3, into a full-length adenine riboswitch RNA and its isolated aptamer domain to monitor the dynamics of the RNAs in vitro and in cell. The adenine riboswitch was sensitive to Mg2+ concentrations and could be used as a biosensor to measure cellular Mg2+ concentrations. Additionally, the TQ3/Cy3-labeled adenine riboswitch yielded a Mg2+ concentration that was similar to that measured using a commercial assay kit.
Furthermore, the fluorescence response to the adenine of the TQ3/Cy3-labeled riboswitch RNA was applied to determine the proportions of multiple RNA conformational changes in cells. The strategy developed in this work can be used to probe the dynamics of other RNAs in cells and may facilitate the developments of RNA biosensors, drugs and engineering.

Circadian Control of REDOX Reactions in the Macrophage Inflammatory Response

Significance: Macrophages are immune sentinels located throughout the body that function in both the amplification and resolution of the inflammatory response. The circadian clock has emerged as a central regulator of macrophage inflammation. Reduction-oxidation (REDOX) reactions are central to both circadian clock and macrophage function. Recent Advances: Circadian regulation of metabolism controls the macrophage inflammatory response, whereby disruption of the clock causes dysfunctional inflammation. Altering metabolism and reactive oxygen/nitrogen species (RONS) production rescues the inflammatory phenotype of clock-disrupted macrophages.
Critical issues: The circadian clock possesses many layers of regulation. Understanding how REDOX reactions coordinate clock function is critical to uncover the full extent of circadian regulation of macrophage inflammation. We provide insights into how circadian regulation of REDOX affects macrophage pattern recognition receptor signaling, immunometabolism, phagocytosis, and inflammasome activation.
Future directions: Many diseases associated with aberrant macrophage derived inflammation exhibit time of day rhythms in disease symptoms and severity and are sensitive to circadian disruption. Macrophage function is highly dependent on REDOX reactions that signal through RONS. Future studies are needed to evaluate the extent of circadian control of macrophage inflammation, specifically in the context of REDOX signaling.

The health consequences of child marriage: a systematic review of the evidence

Background: Child marriage, defined as marriage before 18 years of age, is a violation of human rights and a marker of gender inequality. Growing attention to this issue on the global development agenda also reflects concerns that it may negatively impact health. We conducted a systematic review to synthesize existing research on the consequences of child marriage on health and to assess the risk of bias in this body of literature.
Methods and findings: We searched databases focused on biomedicine and global health for studies that estimated the effect of marrying before the age of 18 on any physical or mental health outcome or health behaviour. We identified 58 eligible articles, nearly all of which relied on cross-sectional data sources from sub-Saharan Africa or South Asia. The most studied health outcomes were indicators of fertility and fertility control, maternal health care, and intimate partner violence. All studies were at serious to critical risk of bias. Research consistently found that women who marry before the age of 18 begin having children at earlier ages and give birth to a larger number of children when compared to those who marry at 18 or later, but whether these outcomes were desired was not considered.
Across studies, women who married as children were also consistently less likely to give birth in health care facilities or with assistance from skilled providers. Studies also uniformly concluded that child marriage increases the likelihood of experiencing physical violence from an intimate partner. However, research in many other domains, including use of contraception, unwanted pregnancy, and sexual violence came to divergent conclusions and challenge some common narratives regarding child marriage.

DMEM/F12

from Elabscience Biotech
PM150312-500mL | 500 mL: 10.00 EUR

DMEM/F12

from Elabscience Biotech
PM150312 | 500mL: 10.00 EUR

DMEM/F12

from MyBiosource
MBS2567519-500mL | 500mL: 80.00 EUR

DMEM/F12

from MyBiosource
MBS2567519-5x500mL | 5x500mL: 360.00 EUR

Special DMEM

from Addexbio
C0003-06 | RT 500 mL Bottle: 66.70 EUR

Optimized DMEM

from Addexbio
C0003-02 | RT 500 mL Bottle: 23.99 EUR

Formulated DMEM

from Addexbio
C0003-01 | RT 500 mL Bottle: 22.99 EUR

Specialized DMEM

from Addexbio
C0003-03 | RT 500 mL Bottle: 30.00 EUR

DMEM/F-12

from Addexbio
C0013-16 | RT 500 mL Bottle: 28.99 EUR

SILAC - DMEM/F12

from AthenaES
0423 | 500 ml: 41.50 EUR

SILAC- DMEM/F12

from AthenaES
0433 | 1L: 33.70 EUR

DMEM/F12, HEPES

from Tribioscience
TBS8083-500ML | 500mL: 36.00 EUR

DMEM/F12, powder

from Elabscience Biotech
PM150312P-110L | 1×10 L: 45.00 EUR

DMEM/F12, powder

from Elabscience Biotech
PM150312P-150L | 1×50 L: 158.00 EUR

DMEM/F12, powder

from Elabscience Biotech
PM150312P-51L | 5×1 L: 35.00 EUR

DMEM/F12 (Powder)

from Abbexa
abx295010-100g | 100 µg: Ask for price

DMEM/F12 (Powder)

from Abbexa
abx295010-20g | 20 µg: 62.50 EUR

DMEM/F12 (Powder)

from Abbexa
abx295010-50g | 50 µg: 162.50 EUR

DMEM/F12, powder

from Elabscience Biotech
PM150312P | 5×1L: 35.00 EUR

DMEM, Low Glucose

from GenDepot
CM014-050 | 500ml: 92.40 EUR

DMEM, Low Glucose

from GenDepot
CM014-300 | 6x500ml: 198.00 EUR

DMEM, Low Glucose

from GenDepot
CM014-310 | 10x500ml: 246.00 EUR

DMEM, Low Glucose

from GenDepot
CM014-320 | 20x500ml: 380.40 EUR
Conclusions: There are many reasons to be concerned about child marriage. However, evidence that child marriage causes the health outcomes described in this review is severely limited. There is more heterogeneity in the results of these studies than is often recognized. For these reasons, greater caution is warranted when discussing the potential impact of child marriage on health. We provide suggestions for avoiding common biases and improving the strength of the evidence on this subject.
Trial registration: The protocol of this systematic review was registered with PROSPERO (CRD42020182652) in May 2020.
Keywords: Child marriage; Social determinants of health; Systematic review.

Magnetic Immobilization and Growth of Nannochloropsis oceanica and Scenedasmus almeriensis

Microalgae are used in industrial and pharmaceutical applications. Their performance on biological applications may be improved by their immobilization. This study presents a way of cell immobilization using microalgae carrying magnetic properties. Nannochloropsis oceanica and Scenedasmus almeriensis cells were treated enzymatically (cellulase) and mechanically (glass beads), generating protoplasts as a means of incorporation of magnetic nanoparticles.
Scanning electron microscopy images verified the successful cell wall destruction for both of the examined microalgae cells. Subsequently, protoplasts were transformed with magnetic nanoparticles by a continuous electroporation method and then cultured on a magnetic surface. Regeneration of transformed protoplasts was optimized using various organic carbon and amino acid supplements. Both protoplast preparation methods demonstrated similar efficiency. Casamino acids, as source of amino acids, were the most efficient compound for N. oceanica protoplasts regeneration in enzymatic and mechanical treatment, while for S. almeriensis protoplasts regeneration, fructose, as source of organic carbon, was the most effective. Protoplasts transformation efficiency values with magnetic nanoparticles after enzymatic or mechanical treatments for N. oceanica and S. almeriensis were 17.8% and 10.7%, and 18.6% and 15.7%, respectively. Finally, selected magnetic cells were immobilized and grown on a vertical magnetic surface exposed to light and without any supplement.

Crassaminicella thermophila sp. nov., a moderately thermophilic bacterium isolated from a deep-sea hydrothermal vent chimney and emended description of the genus Crassaminicella

A novel moderately thermophilic, anaerobic, heterotrophic bacterium (strain SY095T) was isolated from a hydrothermal vent chimney located on the Southwest Indian Ridge at a depth of 2730 m. Cells were Gram-stain-positive, motile, straight to slightly curved rods forming terminal endospores. SY095T was grown at 45-60 °C (optimum 50-55 °C), pH 6.0-7.5 (optimum 7.0), and in a salinity of 1-4.5 % (w/v) NaCl (optimum 2.5 %). Substrates utilized by SY095T included fructose, glucose, maltose, N-acetyl glucosamine and tryptone. Casamino acid and amino acids (glutamate, glutamine, lysine, methionine, serine and histidine) were also utilized. The main end products from glucose fermentation were acetate, H2 and CO2. Elemental sulphur, sulphate, thiosulphate, sulphite, fumarate, nitrate, nitrite and Fe(III) were not used as terminal electron acceptors.
The predominant cellular fatty acids were C14 : 0 (60.5%) and C16 : 0 (7.6 %). The main polar lipids consisted of diphosphatidylglycerol, phosphatidylglycerol, phosphatidylethanolamine, five unidentified phospholipids and two unidentified aminophospholipids. No respiratory quinones were detected. The chromosomal DNA G+C content was 30.8 mol%. The results of phylogenetic analysis of the 16S rRNA gene sequences indicated that SY095T was closely related to Crassaminicella profunda Ra1766HT (95.8 % 16S rRNA gene sequence identity). SY095T exhibited 78.1 % average nucleotide identity (ANI) to C. profunda Ra1766HT. The in silico DNA-DNA hybridization (DDH) value indicated that SY095T shared 22.7 % DNA relatedness with C. profunda Ra1766HT. On the basis of its phenotypic, genotypic and phylogenetic characteristics, SY095T is suggested to represent a novel species of the genus Crassaminicella, for which the name Crassaminicella thermophila sp. nov. is proposed. The type strain is SY095T (=JCM 34213=MCCC 1K04191). An emended description of the genus Crassaminicella is also proposed.

Desulfomarina profundi gen. nov., sp. nov., a novel mesophilic, hydrogen-oxidizing, sulphate-reducing chemolithoautotroph isolated from a deep-sea hydrothermal vent chimney

A novel mesophilic, strictly anaerobic, chemolithoautotrophic sulphate-reducing bacterium, designated strain KT2T, was isolated from a deep-sea hydrothermal vent chimney at the Suiyo Seamount in the Izu-Bonin Arc. Strain KT2T grew at 25-40 °C (optimum 35 °C) and pH 5.5-7.0 (optimum 6.6) in the presence of 25-45 g l-1 NaCl (optimum 30 g l-1). Growth occurred with molecular hydrogen as the electron donor and sulphate, thiosulphate, and sulphite as the electron acceptors. The isolate utilized CO2 as the sole carbon source for chemolithoautotrophic growth on H2. Glycerol, succinate, fumarate, malate, glutamate, or casamino acids could serve as an alternative electron donor in the presence of CO2. Malate, citrate, glutamate, and casamino acids were used as fermentative substrates for weak growth.
The G+C content of genomic DNA was 46.1 %. Phylogenetic analysis of the 16S rRNA gene sequence indicated that strain KT2T is a member of the family Desulfobulbaceae, showing a sequence similarity of 94.3 % with Desulforhopalus singaporensis. Phylogenomic analysis based on concatenated 156 single-copy marker genes confirmed the same topology as the 16S rRNA gene phylogeny. The ANI and AAI values between strain KT2T and related genera of the family Desulfobulbaceae were 65.6-68.6 % and 53.1-62.9 %. Based on the genomic, molecular, and physiological characteristics, strain KT2T represents a novel genus and species within the family Desulfobulbaceae, for which the name Desulfomarina profundi gen. nov., sp. nov. is proposed, with KT2T (=JCM 34118T = DSM 111364T) as the type strain.

Evaluation of immunochromatographic test of Shiga toxin 2e in enrichment cultures of swine edema disease clinical samples

To simplify the diagnosis of swine edema disease, overnight culture supernatants of swine clinical samples were assayed using immunochromatographic test strips we developed previously. Small-intestinal contents, mesenteric lymph nodes, and fecal samples were cultured in casamino acid-yeast extract broth overnight, after which supernatants were loaded onto immunochromatographic test strips to determine whether they could detect Shiga toxin 2e (Stx2e). Among 23 clinical samples in which PCR-identified stx2e-positive E. coli were isolated, samples from seven of ten small-intestinal contents, one of three mesenteric lymph nodes and six of ten fecal samples showed Stx2e-positive reactions in the protein-based immunochromatographic test. Additionally, one small-intestinal content sample, in which stx2e-positive E. coli were not isolated, showed an Stx2e-positive reaction.
Furthermore, the immunochromatographic test results of the samples were associated with the toxin concentration determined by sandwich ELISA and cytotoxicity assay results on Vero cells. The toxin concentration range of the samples with positive and negative reactions were 2.1-196.2 ng/ml and 0-12.8 ng/ml, respectively. The sensitivity and specificity of this immunochromatographic test strip calculated from all clinical samples analyzed in this study were 60.9% and 94.4%, respectively. Our immunochromatographic test strip has strong potential for simple and accurate diagnosis for edema disease by detecting toxin expression, complementing the PCR method.

Staphylococcus aureus Strain-Dependent Biofilm Formation in Bone-Like Environment

Staphylococcus aureus species is an important threat for hospital healthcare because of frequent colonization of indwelling medical devices such as bone and joint prostheses through biofilm formations, leading to therapeutic failure. Furthermore, bacteria within biofilm are less sensitive to the host immune system responses and to potential antibiotic treatments. We suggested that the periprosthetic bone environment is stressful for bacteria, influencing biofilm development. To provide insights into S. aureus biofilm properties of three strains [including one methicillin-resistant S. aureus (MRSA)] under this specific environment, we assessed several parameters related to bone conditions and expected to affect biofilm characteristics. We reported that the three strains harbored different behaviors in response to the lack of oxygen, casamino acids and glucose starvation, and high concentration of magnesium.

Casamino Acids

from Biomatik Corporation
A8507-100G | 100G: 30.80 EUR

Casamino Acids

from Biomatik Corporation
A8507-500G | 500G: 92.40 EUR

Casamino Acids

from Glycomatrix
40300048-1 | 100 g: 47.81 EUR

Casamino Acids

from Glycomatrix
40300048-2 | 500 g: 108.74 EUR

Casamino Acids

from MyBiosource
MBS635444-1kg | 1kg: 260.00 EUR

Casamino Acids

from MyBiosource
MBS635444-25kg | 2.5kg: 520.00 EUR

Casamino Acids

from MyBiosource
MBS635444-500g | 500g: 185.00 EUR

Casamino Acids

from MyBiosource
MBS635444-5kg | 5kg: 830.00 EUR

Casamino Acids

from MyBiosource
MBS635444-5x5kg | 5x5kg: 3515.00 EUR

TSB W/ CASAMINO ACIDS

from Alphabiosciences
T20-134-10kg | 10 kg: 1938.00 EUR

TSB W/ CASAMINO ACIDS

from Alphabiosciences
T20-134-2kg | 2kg: 468.00 EUR

TSB W/ CASAMINO ACIDS

from Alphabiosciences
T20-134-500g | 500 g: 170.40 EUR

Media with Casamino Acids, Sterile

from Glycomatrix
40120876-1 | 1 L: 72.29 EUR

Gibco Difco Casamino Acids Vitamin - EACH

from Scientific Laboratory Supplies
228820 | EACH: 179.19 EUR

Casamino Acid

from Bio Basic
CB3060 | 100g: 74.62 EUR

Casamino Acid (Asicase, Casein Acid Hydrolysate) BactoBio for bacteriology

from Sisco Laboratories
68806-1 | 2 Kg: 106.05 EUR

Casamino Acid (Asicase, Casein Acid Hydrolysate) BactoBio for bacteriology

from Sisco Laboratories
68806-2 | 5 Kg: 248.03 EUR

Casamino Acid (Asicase, Casein Acid Hydrolysate) BactoBio for bacteriology

from Sisco Laboratories
68806 | 500 Gms: 27.37 EUR

Casein acids hydrolysate

from Abbexa
abx082407-100g | 100 g: 276.00 EUR
Each strain presented different biofilm biomass and live adherent cells proportion, or matrix production and composition. However, the three strains shared common responses in a bone-like environment: a similar production of extracellular DNA and engagement of the SOS response. This study is a step toward a better understanding of periprosthetic joint infections and highlights targets, which could be common among S. aureus strains and for future antibiofilm strategies.
Keywords: MRSA; MSSA; biofilms; bone microenvironment; prosthetic joint infection.

Differentiation of canine adipose mesenchymal stem cells into insulin-producing cells: comparison of different culture medium compositions

The aim of this study was to differentiate canine adipose-derived mesenchymal stem cells (ADMSCs) into insulin-producing cells by using culture media with different compositions to determine the most efficient media. Stem cells isolated from the fat tissues close to the bitch uterus were distributed into 6 groups: (1) Dulbecco’s modified Eagle medium (DMEM)-high glucose (HG), β-mercaptoethanol, and nicotinamide; (2) DMEMHG, β-mercaptoethanol, nicotinamide, and exendin-4; (3) DMEMHG, β-mercaptoethanol, nicotinamide, exendin-4, B27, nonessential amino acids, and l-glutamine; (4) DMEMHG, β-mercaptoethanol, and nicotinamide (for the initial 8-d period), and DMEMHG, β-mercaptoethanol, nicotinamide, exendin-4, B27, nonessential amino acids, l-glutamine, and basic fibroblast growth factor (for the remaining 8-d period); (5) DMEMHG and fetal bovine serum; and (6) DMEM-low glucose and fetal bovine serum (standard control group). Adipose-derived mesenchymal stem cells from groups 1 to 5 gradually became round in shape and gathered in clusters.
These changes differed between the groups. In group 3, the cell clusters were apparently more in numbers and gathered as bigger aggregates. Dithizone staining showed that groups 3 and 4 were similar in terms of the mean area of each aggregate stained for insulin. However, only in group 4, the number of insulin aggregates and the total area of aggregates stained were significantly bigger than in the other groups. The mRNA expression of PDX1, BETA2, MafA, and Insulin were also confirmed in all the groups. We conclude that by manipulating the composition of the culture medium it is possible to induce canine ADMSCs into insulin-producing cells, and the 2-staged protocol that was used promoted the best differentiation.

Development of a 3D Tissue-Engineered Skeletal Muscle and Bone Co-culture System.

In vitro 3D tissue-engineered (TE) structures have been shown to better represent in vivo tissue morphology and biochemical pathways than monolayer culture, and are less ethically questionable than animal models. However, to create systems with even greater relevance, multiple integrated tissue systems should be recreated in vitro. In the present study, the effects and conditions most suitable for the co-culture of TE skeletal muscle and bone are investigated. High-glucose Dulbecco’s modified Eagle medium (HGDMEM) supplemented with 20% fetal bovine serum followed by HGDMEM with 2% horse serum is found to enable proliferation of both C2C12 muscle precursor cells and TE85 human osteosarcoma cells, fusion of C2C12s into myotubes, as well as an upregulation of RUNX2/CBFa1 in TE85s.
Myotube formation is also evident within indirect contact monolayer cultures. Finally, in 3D co-cultures, TE85 collagen/hydroxyapatite constructs have significantly greater expression of RUNX2/CBFa1 and osteocalcin/BGLAP in the presence of collagen-based C2C12 skeletal muscle constructs; however, fusion within these constructs appears reduced. This work demonstrates the first report of the simultaneous co-culture and differentiation of 3D TE skeletal muscle and bone, and represents a significant step toward a full in vitro 3D musculoskeletal junction model.

Reduced cystathionine-γ-lyase (CSE) expression is involved in high glucose induced MMP14 expression in adipocytes and adipose tissues.

In the present study, we investigate the effect of reduced cystathionine-γ-lyase (CSE) expression in high glucose induced metalloproteinases14 (MMP14) expression in adipocytes and visceral adipose tissues. Diabetic mice were prepared by injections of STZ and the expression of CSE, MMP14 in visceral adipose tissues were determined. Adipocytes were differentiated from 3T3-L1 cells and treated with high glucose (HG), H2S slow-releasing compound GYY4137 or transfected with CSE siRNA. Then the expression of CSE, MMP14 were determined by western blotting. CSE knockout mice were generated by crossing CSE+/- heterozygous mice and given intraperitoneally (i.p.) injections of GYY4137, and then the expression of CSE and MMP14 in visceral adipose tissues were determined by quantitative real-time PCR and western blotting.
The following results were obtained from the study. In adipose tissues of diabetic mice, the mRNA and protein expression of MMP14 increased while the mRNA and protein expression of CSE decreased. In 3T3-L1 adipocytes, both HG DMEM and CSE siRNA transfection increased the mRNA and protein of MMP14. The addition of GYY4137 inhibited HG-induced upregulation of MMP14 expression. In CSE knockout mice, the mRNA and protein expression of MMP14 in adipose tissues increased, which could be inhibited by i.p. injections of GYY4137. In conclusion, high glucose increased the expression of MMP14 in adipocytes and visceral adipose tissues through inhibiting the expression of CSE.

Probucol promotes high glucose-induced proliferation and inhibits apoptosis by reducing reactive oxygen species generation in Müller cells.

To explore the protective effect of probucol on human retinal Müller cells cultured in high glucose.Primary Müller cells from human retinas were cultured in complete DMEM. Third-generation Müller cells were identified using glutamine synthetase (GS) antibody and randomly divided into three groups: normoglycemia (NG, 5.5 mmol/L); hyperglycemia (HG, 30 mmol/L); and hyperglycemia (30 mmol/L) with probucol (10 μmol/L; HGPB). After a 24-h intervention, cell proliferation, apoptosis, and cellular reactive oxygen species (ROS) were measured with a CCK-8 kit, flow cytometry, and DCFH-DA probe, respectively. Kelch-like ECH-associated protein 1 (Keap1), NF-E2-related factor 2 (Nrf2), and glutamate cysteine ligase catalytic subunit (GCLC) protein expression were detected by immunofluorescence staining.
For NG, HG, and HGPB, optical density (OD) values for cell proliferation were 0.98 ± 0.23, 0.58 ± 0.11, and 0.73 ± 0.11; apoptotic rates were 2.79 ± 0.52%, 7.70 ± 0.44%, and 4.00 ± 0.95%; and intracellular ROS were 20.89 ± 5.14, 55.17 ± 14.07, and 26.28 ± 4.73, respectively. Compared to NG, OD was markedly decreased (P < 0.01), apoptosis was increased (P < 0.001), and intracellular ROS level was significantly higher than in HG (P < 0.01). Compared to HG, OD was markedly increased (P < 0.01), apoptosis was meaningfully decreased (P < 0.01), and intracellular ROS level was significantly lower than in HGPB (P < 0.01). GS, Keap1, Nrf2, and GCLC had positive expression. Probucol could inhibit intracellular ROS generation, promote proliferation, and decrease apoptosis of human retinal Müller cells cultured in high glucose. This might also be associated with Keap1/Nrf2/ARE oxidative stress signaling pathway activation.

High Glucose-reduced Apoptosis in Human Breast Cancer Cells Is Mediated by Activation of NF-κB.

Tumor cells rely on glycolysis for their energy supply with the production of lactate even in normoxia condition, which is named aerobic glycolysis or Warburg effect. Therefore, high glucose (HG) concentration provides a favorable condition for increasing proliferation, angiogenesis and decreasing apoptosis, but its molecular mechanisms are still unknown. The objective of this study is to investigate HG condition on tumor cells behavior including proliferation, apoptosis, and an angiogenesis mediator. In this study, MCF-7 derived from human breast adenocarcinoma, were cultured in DMEM with two different concentrations of glucose for 48 h (5.5 mM as normal glucose (NG) condition and 25 mM as HG condition).

DMEM (HG) With high-glucose, L-glutamine, and sodium pyruvate.

from Caisson Labs
DML10-1000ML | 1000 ml: 96.00 EUR

DMEM (HG) With high-glucose, L-glutamine, and sodium pyruvate.

from Caisson Labs
DML10-500ML | 500 ml: 85.20 EUR

DMEM (HG) With high-glucose, L-glutamine, and sodium pyruvate.

from Caisson Labs
DML10-6X1000ML | 6 x 1000 ml: 177.60 EUR

DMEM (HG) With high-glucose, L-glutamine, and sodium pyruvate.

from Caisson Labs
DML10-6X500ML | 6 x 500 ml: 121.20 EUR

DMEM (HG) With high-glucose, L-glutamine, and sodium pyruvate.

from Caisson Labs
DML26-500ML | 500 ml: 110.40 EUR

DMEM (HG) With high-glucose, L-glutamine, and sodium pyruvate.

from Caisson Labs
DML26-6X500ML | 6 x 500 ml: 260.40 EUR

DMEM (HG) With High Glucose and Sodium Pyruvate. W/O Amino Acids.

from Caisson Labs
DML27-500ML | 500 ml: 115.20 EUR

DMEM (HG) With High Glucose and Sodium Pyruvate. W/O Amino Acids.

from Caisson Labs
DML27-6X500ML | 6 x 500 ml: 274.80 EUR

DMEM (HG) With high-glucose. W/O L-glutamine or sodium pyruvate.

from Caisson Labs
DML18-500ML | 500 ml: 88.80 EUR

DMEM (HG) With high-glucose. W/O L-glutamine or sodium pyruvate.

from Caisson Labs
DML18-6X500ML | 6 x 500 ml: 139.20 EUR
We used Zingiber officinale extraction for the inhibition of NF-κB. Cell proliferation assay was done by direct counting, cell viability by MTT method, bcl-2 by Immunocytochemistry, apoptosis by Hoechst/PI double staining and vascular endothelium growth factor (VEGF) by ELISA.
Results showed that HG increased lactate production, significantly. HG increased cell proliferation, cell viability, VEGF secretion, and bcl-2 expression while it decreased apoptosis. However, when HG was combined with Zingiber officinale extraction, cell proliferation, cell viability, VEGF secretion and bcl-2 expression decreased and apoptosis increased significantly due to inhibition of NF-κB. Results revealed that HG increased cell proliferation, angiogenesis and decreased apoptosis due to activation of NF-κB pathway. Moreover, the probable mechanism of the activation of NF-κB in HG is increasing reactive oxygen species (ROS) in this condition that can activate NF-κB directly.

Microbe-derived antioxidants attenuate cobalt chloride-induced mitochondrial function, autophagy and BNIP3-dependent mitophagy pathways in BRL3A cells

Environmental excessive cobalt (Co) exposure increases risks of public health. This study aimed to evaluate the potential mechanism of microbe-derived antioxidants (MA) blend fermented by probiotics in attenuating cobalt chloride (CoCl2)-induced toxicology in buffalo rat liver (BRL3A) cells. Herein, results showed that some phenolic acids increased in MA compared with the samples before fermentation through UHPLC-QTOF-MS analysis. Also, the contents of essential and non-essential amino acids, their derivatives and minerals were rich in MA. The DPPH, O2, OH and ABTS+ scavenging ability of MA is comparable to those of vitamin C and better than mitoquinone mesylate (mitoQ).
In vitro cell experiments showed that CoCl2 treatment increased the percentage of apoptosis cells, lactate dehydrogenase and genes involved in glycolysis, increased ATP production and decreased mitochondrial membrane potential, increased genes involved in canonical autophagy process (including initiation, autophagosomes maturation and fusion with lysosome) and BNIP3-dependent mitophagy pathways in BRL3A cells, while MA attenuated CoCl2-induced reactive oxygen species (ROS) production, apoptosis, mitochondrial protein expression and dysfunction, and BNIP3-dependent mitophagy. Collectively, these results provide insights into the role of MA in reversing CoCl2-induced toxicology in BRL3A cells, providing the promising constituents for decreasing Co-induced toxicology in functional foods.

Cardioprotective effects of alantolactone on isoproterenol-induced cardiac injury and cobalt chloride-induced cardiomyocyte injury

Objectives: Alantolactone (AL) is a compound extracted from the roots of Inula Racemosa that has shown beneficial effects in cardiovascular disease. However, the cardioprotective mechanism of AL against hypoxic/ischemic (H/I) injury is still unclear. This research aimed to determine AL’s ability to protect the heart against isoproterenol (ISO)-induced MI injury in vivo and cobalt chloride (CoCl2) induced H/I injury in vitro.
Methods: Electrocardiography (ECG), lactate dehydrogenase (LDH), creatine kinase (CK), and cardiac troponin I (cTnI) assays in addition to histological analysis of the myocardium were used to investigate the effects of AL in vivo. Influences of AL on L-type Ca2+ current (ICa-L) in isolated rat myocytes were observed by the patch-clamp technique. Furthermore, cell viability, apoptosis, oxidative stress injury, mitochondrial membrane potential, and intracellular Ca2+ concentration were examined in vitro.
Results: The results indicated that AL treatment ameliorated the morphological and ECG changes associated with MI, and decreased levels of LDH, CK, and cTnI. Furthermore, pretreatment with AL elevated antioxidant enzyme activity and suppressed ROS production. AL prevented H/I-induced apoptosis, mitochondria damage, and calcium overload while reducing ICa-L in a concentration and time dependent fashion. The 50% inhibiting concentration (IC50) and maximal inhibitory effect (Emax) of AL were 17.29 μmol/L and 57.73 ± 1.05%, respectively.
Conclusion: AL attenuated MI-related injury by reducing oxidative stress, apoptosis, calcium overload, and mitochondria damage. These cardioprotective effects may be related to the direct inhibition of ICa-L.
Keywords: L-type calcium channel currents; alantolactone; calcium influx; cardio-protection; oxidative stress.

Tongxin formula protects H9c2 cardiomyocytes from cobalt chloride-induced hypoxic injury via inhibition of apoptosis

In this study, the effect of the Tongxin formula (TXF) on the apoptosis of H9c2 cardiomyocytes induced by cobalt chloride (CoCl2) was investigated, and the potential mechanism was explored. A hypoxic injury model of H9c2 cardiomyocytes was established using CoCl2. The cell viability was measured using a Cell Counting Kit-8 assay. The lactate dehydrogenase (LDH) release and caspase-3 activity were measured using spectrophotometry. The apoptosis was measured via Annexin V-FITC/PI staining and flow cytometry. The changes in the mitochondrial membrane potential were examined using immunofluorescence microscopy following the loading of JC-1 probes.
The expressions of apoptosis-related proteins and key proteins in the phosphatidylinositol 3-kinase/protein kinase B (PI3K/Akt) pathway were examined via immunoblotting. The different TXF concentrations studied significantly improved the percentage of viability of cardiomyocytes with hypoxic injury, and the LDH release, apoptotic rate, caspase-3 activity, and levels of cleaved caspase-3 protein were reduced in the injured cells. Additionally, the TXF group had increased mitochondrial membrane potential, upregulated expression of Bcl-2 and p-Akt proteins, and significantly reduced expression of cleaved caspase-3 protein in the cells with hypoxic injury.
Moreover, in the TXF group, the treatment significantly reduced the BAX protein expression, but the difference was not statistically significant compared with the CoCl2 group. In this study, TXF regulated the expression of apoptosis-related proteins, inhibited apoptosis, increased the mitochondrial membrane potential, and alleviated damage to the mitochondrial membrane, thereby protecting the cardiomyocytes from hypoxic injury. The underlying mechanism could be related to activation of the PI3K/Akt signaling pathway and upregulation of the Bcl-2 protein.

The biological effect of cobalt chloride mimetic-hypoxia on nucleus pulposus cells and the comparability with physical hypoxia in vitro

Objective: Nucleus pulposus cells (NPCs) are cells e induce mimetic-hypoxia for NPCs and the comparison withxtracted from the intervertebral disc and are important for research into intervertebral disc degeneration (IVDD). NPCs live in an avascular and relatively hypoxic environment. Cobalt chloride (CoCl2) has been used in many cell studies to mimic hypoxia. The objective of this study was to explore the possibility of using CoCl2 to hypoxia (1% O2in vitro.
 Materials and methods: Rat nucleus pulposus cells of Passage 3-5 were used in this research. Cell viability, rate of cell apoptosis, ROS (reactive oxygen species) generation, cell migration, extracellular pH and extracellular matrix metabolism were determined to compare the influence of hypoxia (1% O2) and CoCl2 on NPCs.
Results: We found that the effects of CoCl2 on NPCs was dose-dependent. At the proper concentration, CoCl2 could be used to elicit chemical hypoxia for nucleus pulposus cells in vitro and many biological effects, analogous to physical hypoxia (1% O2), could be achieved such as enhanced cell viability, decreased apoptosis and activated extracellular matrix metabolism. On the other hand, CoCl2 mimetic-hypoxia did not affect NPCs glycolysis and migration compared to physical hypoxia. In addition, high concentration of CoCl2 (>200 μM) is harmful to NPCs with high rates of apoptosis and ECM (extracellular matrix) degradation.
 Conclusions: It is feasible and convenient to use CoCl2 to induce chemical mimetic hypoxia for culturing NPCs on the premise of appropriate concentration. But in aspects of cell migration and glycolysis, CoCl2 could not achieve similar results with physical hypoxia. This study may provide a convenient method and enlightenment to induce mimetic-hypoxia for researchers studying NPCs and IVVD.
Keywords: Apoptosis; Cobalt chloride; Extracellular matrix synthesis; Hypoxia; Migration; Nucleus pulposus cells.

Synthesis and structure determination of racemic (Δ/Λ)-tris-(ethyl-enedi-amine)-cobalt(III) trichloride hemi(hexa-aqua-sodium chloride)

The synthesis and crystal structure of the title racemic compound, [Co(C2H8N2)3]Cl3.{[Na(H2O)6]Cl}0.5, are reported. The trivalent cobalt atom, which resides on a crystallographic threefold axis, is chelated by a single ethyl-ene di-amine (en) ligand and yields the tris-chelate [Co(en)3]3+ cation with distorted octa-hedral geometry after the application of crystal symmetry.

COBALT CHLORIDE

from PhytoTechnology Laboratories
C350 | 100G: 19.49 EUR

Cobalt Chloride 0.5M

from Glycomatrix
40100364-1 | 100 ml: 27.17 EUR

Cobalt Chloride 0.5M

from Glycomatrix
40100364-2 | 250 ml: 44.47 EUR

Cobalt(II) Chloride

from Toronto Research Chemicals
C633108 | 1g: 63.00 EUR

Cobalt chloride hexahydrate

from EWC Diagnostics
PCT0103-100G | 1 unit: 24.39 EUR

Cobalt chloride hexahydrate

from EWC Diagnostics
PCT0103-500G | 1 unit: 109.83 EUR

Cobalt(II) Chloride Hydrate

from Toronto Research Chemicals
C633110 | 1g: 81.00 EUR

Platinum cobalt chloride 99.9 %

from Pfaltz & Bauer
P21080 | 1G: 514.95 EUR

Cobalt(Ⅱ) Chloride, Anhydrous

from NACALAI TESQUE
09208-72 | 25G: 16.10 EUR

Cobalt(II) Chloride Anhydrous

from Glycomatrix
40000075-1 | 25 g: 82.37 EUR

Cobalt(II) Chloride Anhydrous

from Glycomatrix
40000075-2 | 100 g: 274.52 EUR

Cobalt(II) chloride, anhydrous

from Glentham Life Sciences
GK0658 | 25g: 130.36 EUR

Cobalt(II) chloride, anhydrous

from Glentham Life Sciences
GK0658-100 | 100: 43.50 EUR

Cobalt(II) chloride, anhydrous

from Glentham Life Sciences
GK0658-100G | 100 g: 88.80 EUR

Cobalt(II) chloride, anhydrous

from Glentham Life Sciences
GK0658-25 | 25: 18.20 EUR

Cobalt(II) chloride, anhydrous

from Glentham Life Sciences
GK0658-250 | 250: 79.10 EUR

Cobalt(II) chloride, anhydrous

from Glentham Life Sciences
GK0658-250G | 250 g: 132.00 EUR

Cobalt(II) chloride, anhydrous

from Glentham Life Sciences
GK0658-25G | 25 g: 57.60 EUR

Cobalt(II) chloride, anhydrous

from Glentham Life Sciences
GK0658-500 | 500: 142.40 EUR

Cobalt(II) chloride, anhydrous

from Glentham Life Sciences
GK0658-500G | 500 g: 208.80 EUR
The sodium cation (site symmetry ), has a single water mol-ecule bound to it in the asymmetric unit and yields a distorted, octa-hedrally coordinated hydrated [Na(H2O)6]+ cation after the application of symmetry. One of the chloride ions lies on a general position and the other has site symmetry. An extensive array of C-HO, N-HCl and O-HCl hydrogen bonds exists between the ethyl-ene di-amine ligands, the water mol-ecules of hydration, and the anions present, thereby furnishing solid-state stability.
Keywords: crystal structure; enanti­omer; ethyl­ene di­amine; racemate.